Document is current
Any future updates will be listed below
-
Authors
Xu, Li https://orcid.org/0009-0003-6836-3537
Wang, Yingcong
Wang, Guanli
Guo, Shushan
Yu, Dandan
Feng, Qilin
Hu, Ke
Chen, Gege
Li, Bo https://orcid.org/0000-0002-4279-4596
Xu, Zhijian https://orcid.org/0000-0002-3063-8473
Jia, Xinyan
Lu, Yumeng
Zhang, Hui
Gao, Xuejie
Chang, Shuaikang
Wang, Huaping
Wu, Xiaosong
Song, Dongliang
Yang, Guang
Zhu, Huabin
Zhou, Jinfeng
Zhan, Fenghuang https://orcid.org/0000-0001-5417-2973
Zhu, Weiliang https://orcid.org/0000-0001-6699-5299
Shi, Jumei https://orcid.org/0000-0002-8553-4559
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81870158)
National Natural Science Foundation of China (82170200)
National Natural Science Foundation of China (81900207)
National Natural Science Foundation of China (22077131)
National Natural Science Foundation of China (82070224)
National Natural Science Foundation of China (81971529)
National Natural Science Foundation of China (82000220)
Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Projiect
- License Information
-
More Information
Article History
Received: 24 January 2023
Revised: 24 April 2023
Accepted: 28 April 2023
First Online: 8 May 2023
Competing interests
: The authors declare no competing interests.
